目的 探讨标准化舌下免疫治疗（sublingual immunotherapy，SLIT）过敏性疾病患儿的人口学特征，并分析依从性的影响因素。 方法 纳入江西省儿童医院2018年1月1日—2020年12月31日接受SLIT的1 789例过敏性疾病患儿为研究对象，回顾性分析患儿的人口学特征和随访资料，分析SLIT的依从性及其影响因素。 结果 共1 789例SLIT患儿，其中男性1 271例（71.05%），女性518例（28.95%），年龄4~14岁；完全依从777例（43.43%）；脱落1 012例（56.57%），因自觉使用不便脱落354例（34.98%），因疗效欠佳脱落346例（34.19%），因症状改善自行停用253例（25.00%），因不良反应停用的59例（5.83%）。脱落主要集中在开始治疗后1~4个月（74.31%，752/1 012）。女性患儿依从率低于男性患儿，患单一疾病者依从率低于患多种疾病者（P<0.05）。多因素分析结果显示，与男性相比，女性发生脱落的风险增加（OR=0.811，95%CI：0.658~0.998，P<0.05）；相对于患多种疾病者，患单一疾病者发生脱落的可能性增加（OR=1.313，95%CI：1.005~1.715，P<0.05）。 结论 过敏性疾病患儿SLIT依从性不理想，与患儿性别、所患疾病数量等特征有关；主要脱落原因为自觉使用不便和疗效欠佳。
Abstract
Objective To study the demographic features of children with allergic diseases receiving standardized sublingual immunotherapy (SLIT) and the influencing factors for the compliance with SLIT. Methods A retrospective analysis was performed on the demographic features and follow-up data of 1 789 children with allergic diseases who received SLIT in Children's Hospital of Jiangxi Province from January 1, 2018 to December 31, 2020. The compliance with SLIT and its influencing factors were analyzed. Results A total of 1 789 children received SLIT, among whom there were 1 271 boys (71.05%) and 518 girls (28.95%), with an age range of 4-14 years. Among these children, 777 (43.43%) had complete compliance with SLIT and 1 012 (56.57%) withdrew from the treatment within one year. Among the 1 012 children, 354 (34.98%) withdrew from the treatment due to self-conscious inconvenient use, 346 (34.19%) withdrew due to unsatisfactory treatment outcome, 253 (25.00%) stopped the treatment due to the improvement in symptoms, and 59 (5.83%) terminated the treatment due to adverse reactions. Withdrawal was mainly observed within 1-4 months after treatment (74.31%, 752/1 012). Girls tended to have a lower compliance rate than boys, and the children with a single disease had a lower compliance rate than those with multiple diseases (P<0.05). The multivariate analysis showed that compared with boys, girls had an increased risk of withdrawal (OR=0.811, 95%CI: 0.658-0.998, P<0.05), and compared with the children with multiple diseases, the children with a single disease were more likely to withdraw from the treatment (OR=1.313, 95%CI: 1.005-1.715, P<0.05). Conclusions Children with allergic diseases tend to have poor compliance with SLIT, which is associated with sex and the number of diseases, and the main reasons for withdrawal are self-conscious inconvenient use and unsatisfactory treatment outcome.
关键词
舌下免疫治疗 /
过敏性疾病 /
人口学特征 /
依从性 /
儿童
Key words
Sublingual immunotherapy /
Allergic disease /
Demographic feature /
Compliance /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 罗向前, 刘大波. 儿童过敏性鼻炎的流行病学[J]. 中国实用儿科杂志, 2019, 34(3): 197-199. DOI: 10.19538/j.ek2019030609.
2 向莉, 赵京, 鲍一笑, 等. 儿童气道过敏性疾病螨特异性免疫治疗专家共识[J]. 中华实用儿科临床杂志, 2018, 33(16): 1215-1223. DOI: 10.3760/cma.j.issn.2095-428X.2018.16.005.
3 Li H, Chen S, Cheng L, et al. Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma[J]. J Thorac Dis, 2019, 11(12): 4936-4950. PMID: 32030209. PMCID: PMC6988076. DOI: 10.21037/jtd.2019.12.37.
4 Kim JA, Lee YM, Yi KI, et al. Comparative analysis of sublingual immunotherapy medicines for adherence and clinical outcomes[J]. Eur Arch Otorhinolaryngol, 2020, 277(1): 135-140. PMID: 31542829. DOI: 10.1007/s00405-019-05656-6.
5 Vogelberg C, Brüggenjürgen B, Richter H, et al. Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma[J]. Patient Prefer Adherence, 2020, 14: 817-827. PMID: 32494127. PMCID: PMC7231771. DOI: 10.2147/PPA.S242957.
6 Incorvaia C, Mauro M, Leo G, et al. Adherence to sublingual immunotherapy[J]. Curr Allergy Asthma Rep, 2016, 16(2): 12. PMID: 26758865. DOI: 10.1007/s11882-015-0586-1.
7 Musa F, Al-Ahmad M, Arifhodzic N, et al. Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies[J]. Hum Vaccin Immunother, 2017, 13(3): 514-517. PMID: 27820664. PMCID: PMC5360151. DOI: 10.1080/21645515.2016.1243632.
8 向莉, 申昆玲, 张亚梅, 等. 3～14岁哮喘和变应性鼻炎患儿吸入性致敏原分布特征比较[J]. 中国实用儿科杂志, 2006, 21(8): 581-583. DOI: 10.3969/j.issn.1005-2224.2006.08.010.
9 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016年版)[J]. 中华儿科杂志, 2016, 54(3): 167-181. PMID: 26957061. DOI: 10.3760/cma.j.issn.0578-1310.2016.03.003.
10 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(2015年, 天津)[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(1): 6-24. PMID: 26791765. DOI: 10.3760/cma.j.issn.1673-0860.2016.01.004.
11 中华医学会皮肤性病学分会儿童皮肤病学组. 中国儿童特应性皮炎诊疗共识(2017版)[J]. 中华皮肤科杂志, 2017, 50(11): 784-789. DOI: 10.3760/cma.j.issn.0412-4030.2017.11.002.
12 中华医学会眼科学分会角膜病学组. 我国过敏性结膜炎诊断和治疗专家共识(2018年)[J]. 中华眼科杂志, 2018, 54(6): 409-414. DOI: 10.3760/cma.j.issn.0412-4081.2018.06.003.
13 刘湘, 楼响瑜, 高月秋, 等. 变应性鼻炎患者变应原谱及舌下免疫治疗分析[J]. 中国耳鼻咽喉头颈外科, 2019, 26(9): 491-494. DOI: 10.16066/j.1672-7002.2019.09.007.
14 Chen WB, Shen XF, Li Q, et al. Efficacy of a 3-year course of sublingual immunotherapy for mite-induced allergic rhinitis with a 3-year follow-up[J]. Immunotherapy, 2020, 12(12): 891-901. PMID: 32693660. DOI: 10.2217/imt-2020-0006.
15 Liu W, Zeng Q, Luo R. Predictors for short-term efficacy of allergen-specific sublingual immunotherapy in children with allergic rhinitis[J]. Mediators Inflamm, 2020, 2020: 1847061. PMID: 32377158. PMCID: PMC7191440. DOI: 10.1155/2020/1847061.
16 Kim JY, Rhee CS, Mun SJ, et al. Early response of specific IgE can predict satisfaction with sublingual immunotherapy[J]. Laryngoscope, 2021, 131(3): 467-472. PMID: 32562508. DOI: 10.1002/lary.28762.
17 李添应, 陈德华, 林志斌, 等. 舌下含服粉尘螨滴剂治疗变应性鼻炎的疗效观察[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(10): 859-862. DOI: 10.3760/cma.j.issn.1673-0860.2011.10.014.
18 朱振潮, 邱前辉, 陈卓, 等. 变应性鼻炎常规免疫治疗与冲击免疫治疗的临床疗效与依从性分析[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(2): 81-86. PMID: 29757549. DOI: 10.13201/j.issn.1001-1781.2018.02.001.
19 阮宇, 张媛, 赵亚丽, 等. 过敏性鼻炎粉尘螨舌下免疫治疗电子问卷依从性分析[J]. 中国耳鼻咽喉头颈外科, 2022, 29(2): 107-110. DOI: 10.16066/j.1672-7002.2022.02.010.
20 Yung JA, Fuseini H, Newcomb DC. Hormones, sex, and asthma[J]. Ann Allergy Asthma Immunol, 2018, 120(5): 488-494. PMID: 29410216. PMCID: PMC5936670. DOI: 10.1016/j.anai.2018.01.016.
21 Wijga A, Tabak C, Postma DS, et al. Sex differences in asthma during the first 8 years of life: the prevention and incidence of asthma and mite allergy (PIAMA) birth cohort study[J]. J Allergy Clin Immunol, 2011, 127(1): 275-277. PMID: 21094994. DOI: 10.1016/j.jaci.2010.09.022.
22 叶茂鑫, 刘传合, 沙莉, 等. 过敏性鼻炎儿童发生支气管哮喘的影响因素分析[J]. 中国学校卫生, 2021, 42(9): 1302-1305. DOI: 10.16835/j.cnki.1000-9817.2021.09.007.
基金
江西省卫生健康委科技计划（202110104）。
PDF(529 KB)
